Kambiz Yazdi
Stock Analyst at BTIG
(3.03)
# 1,384
Out of 5,058 analysts
11
Total ratings
75%
Success rate
47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Initiates: Buy | $40 | $32.24 | +24.07% | 1 | Nov 19, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $424 | $189.32 | +123.96% | 3 | Nov 19, 2025 | |
| SION Sionna Therapeutics | Initiates: Buy | $50 | $38.41 | +30.17% | 1 | Nov 19, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $47 | $26.88 | +74.85% | 1 | Nov 19, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $17.59 | +30.76% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $27.89 | -31.88% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $14.28 | +5.04% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.36 | +267.65% | 1 | Apr 12, 2024 |
vTv Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $40
Current: $32.24
Upside: +24.07%
Praxis Precision Medicines
Nov 19, 2025
Initiates: Buy
Price Target: $424
Current: $189.32
Upside: +123.96%
Sionna Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $50
Current: $38.41
Upside: +30.17%
Rapport Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $47
Current: $26.88
Upside: +74.85%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $17.59
Upside: +30.76%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $27.89
Upside: -31.88%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $14.28
Upside: +5.04%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.36
Upside: +267.65%